Epstein Secrets

From: Joi Ito To: Jeffrey Epstein <[email protected]> Subject: Re: OH2 Investment Date: Mon, 17 Nov 2014 14:58:18 +0000 Thanks. I'm going through the documents with my lawyer

parallel, I'm finding out if there is any conflict of interest issues from MIT with respect to my involvement. - Joi > On Nov 17, 2014, at 09:54 , jeffrey E. <[email protected]> wrote: > ------- Forwarded messa e > From: Darren Indyke > Date: Monday, November 17, 2014 > Subject: OH2 Investment > To:

ct: OH2 Investment >> Date: November 15, 2014 at 5:48:33 PM EST , Jeffrey Epstein Jeremy Heckman , "Darren K. Indyke" >> To: Alexander Lourie >> Jeffrey, here are the docs for the investment. I'll send more details on the science in a separate email. >> They are trying to raise $500K+ this round and

From: Joi Ito To: Jeffrey Epstein <[email protected]> Subject: Re: OH2 Investm

g units to third parties by Unit holders. Not sure if Joi has any Board representation. The initial Board of Managers consists of: > Ayaz Mahmud > David Levy > Mark Rioult > Jean-Marie Vallet and > Steve Yang, > DARREN K. INDYKE > DARREN K. INDYKE, PLLC > 575 Lexington Avenue, 4th Floor EFTA00689370

From: Joichi Ito Sent: Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now how it goes. Joi > On Jan 13, 2015, at 3:49 PM, jeffrey E. <[email protected]> wrote: > ok >

ay, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now how it goes. Joi > On Jan 13, 2015, at 3:49 PM, jeffrey E. <[email protected]> wrote: > ok > On Tue, Jan 13, 2015 at 4:39 PM, Joichi Ito wrote: > This is the electronic nose project. Dealing with the co

Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now

o Sent: Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let

I risk has been well-addressed and =an permit this investment to go forward. » Thank you for your consideration and assistance. » Kind regards, » David Levy, Ph.D. '92, SM '87, 58'87 > please note > The information contained in this communication is confidential, may > be attorney-client privileged, ma

From: Joichi Ito < Sent: Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now how it goes. Joi > On Jan 13, 2015, at 3:49 PM, jeffrey E. <[email protected]> wrote: > ok >

ay, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now how it goes. Joi > On Jan 13, 2015, at 3:49 PM, jeffrey E. <[email protected]> wrote: > ok > On Tue, Jan 13, 2015 at 4:39 PM, Joichi Ito <-> wrote: > This is the electronic nose project. Dealing with th

Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now

< Sent: Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let

I risk has been well-addressed and =an permit this investment to go forward. » Thank you for your consideration and assistance. » Kind regards, » David Levy, Ph.D. '92, SM '87, 58'87 > please note > The information contained in this communication is confidential, may > be attorney-client privileged, ma

Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now

o Sent: Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let

From: Joichi Ito Sent: Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now how it goes. Joi > On Jan 13, 2015, at 3:49 PM, jeffrey E. <[email protected]> wrote: > ok >

ay, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now how it goes. Joi > On Jan 13, 2015, at 3:49 PM, jeffrey E. <[email protected]> wrote: > ok > On Tue, Jan 13, 2015 at 4:39 PM, Joichi Ito wrote: > This is the electronic nose project. Dealing with the co

I risk has been well-addressed and =an permit this investment to go forward. » Thank you for your consideration and assistance. » Kind regards, » David Levy, Ph.D. '92, SM '87, 58'87 > please note > The information contained in this communication is confidential, may > be attorney-client privileged, ma

From: Joichi Ito Sent: Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now how it goes. Joi > On Jan 13, 2015, at 3:49 PM, jeffrey E. <[email protected]> wrote: > ok >

ay, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now how it goes. Joi > On Jan 13, 2015, at 3:49 PM, jeffrey E. <[email protected]> wrote: > ok > On Tue, Jan 13, 2015 at 4:39 PM, Joichi Ito wrote: > This is the electronic nose project. Dealing with the co

Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let you now

o Sent: Tuesday, January 13, 2015 8:59 PM To: Jeffrey Epstein Subject: Re: update Thanks. Will let

I risk has been well-addressed and =an permit this investment to go forward. » Thank you for your consideration and assistance. » Kind regards, » David Levy, Ph.D. '92, SM '87, 58'87 > please note > The information contained in this communication is confidential, may > be attorney-client privileged, ma

From: "Jeffrey E." <[email protected]> To: Joichi Ito <Ma> Sub

From: "Jeffrey E." <[email protected]> To: Joichi Ito <Ma>

the COI risk has been well-addressed and can permit this investment to go forward. Thank you for your consideration and assistance. Kind regards, David Levy, '92, SM '87, SB '87 please note The information contained in this communication is confidential, may be attorney-client privileged, may constit

From: jeffrey E. <[email protected]> Sent: Sunday, November 16, 2014 9:41 AM To: Joi Ito Subject: Re: GPCR we should just know ore about 2nd round, so we are

nce. The investment vehicle is basically a holding=company for the technology that will spin out in various applications incl=ding biomedical, etc. Jeffrey, this is being done in Ne=l Gershenfeld's Lab, CBA. -Joi Begin forwarded message: =br> Hi Joi,<=iv style="font-family:Helvetica;font-size:12px;fo

regated proteins.4, EFTA_R1_01779011 EFTA02594854 I am very pleased that you are very interested in taking a su=-licensing of our invention. Dr. David Levy, the Managing Director o= OH2Laboratories and Dr. Marc Rioult, former MIT TLO Senior Officer will t=ke lead on the negotiation. They are very exper

From: jeffrey E. <[email protected]> Sent: Tuesday, January 13, 2015 8:50 PM To: Joichi Ito Subject: Re: update ok On Tue, Jan 13, 2015 at 4:39 PM, Joichi I

OI risk has been well-addressed and can permit this investment to go for=ard. Thank you for your consideration and assistance. Kind regards, =br> David Levy, Ph.D. '92, SM '=7, SB '87 2 EFTA_R1_01646626 EFTA02513455 4> please note The information contained in this communicati=n is confidential, ma